(Q40886502)

24 September 2017

1 reference

title

Poxvirus vectors: cytoplasmic expression of transferred genes (English)

1 reference

24 September 2017

Moss B

1

1 reference

24 September 2017

publication date

1 February 1993

1 reference

Current Opinion in Genetics & Development

24 September 2017

published in

1 reference

24 September 2017

volume

3

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

86-90

1 reference

Vaccinia virus: a tool for research and vaccine development

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Vaccinia virus vectors for gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Manipulation of vaccinia virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Isolation and handling of recombinant vaccinia viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

The hygromycin-resistance-eneoding gene as a selection marker for vaccinia virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Direct identification of recombinant vaccinia virus plaques by PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Introduction of foreign DNA into the vaccinia virus genome by in vitro ligation: recombination-independent selectable cloning vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Infectious defective interfering particles of VSV from transcripts of a cDNA clone

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Vaccinia-T7 RNA polymerase expression system: evaluation for the expression cloning of plasma membrane transporters

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Enhancement of the vaccinia virus/phage T7 RNA polymerase expression system using encephalomyocarditis virus 5'-untranslated region sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Regulated expression of nuclear genes by T3 RNA polymerase and lac repressor, using recombinant vaccinia virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Molecular attenuation of vaccinia virus: mutant generation and animal characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Identification and characterization of two nonessential regions of the rabbitpox virus genome involved in virulence

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

NYVAC: a highly attenuated strain of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Protein of macaques against infection with simian type D retrovirus (SRV-1) by immunization with recombinant vaccinia virus expressing the envelope glycoproteins of either SRV-1 or Mason-Pfizer monkey virus (SRV-3)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Successful oral rabies vaccination of raccoons with raccoon poxvirus recombinants expressing rabies virus glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Efficacy studies on a canarypox-rabies recombinant virus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Construction of a pigeonpox virus recombinant: expression of the Newcastle disease virus (NDV) fusion glycoprotein and protection of chickens against NDV challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Potential use of non-replicating vectors as recombinant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Recombinant fowlpox virus inducing protective immunity in non-avian species

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Immunisation with canarypox virus expressing rabies glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Fowlpox virus recombinant encoding the measles virus fusion protein: protection of mice against fatal measles encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

Nonreplicating viral vectors as potential vaccines: Recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980346-6

7 January 2021

10.1016/S0959-437X(05)80346-6

Identifiers

DOI

1 reference

24 September 2017

1 reference